Study reports cost-effectiveness of population genetic testi

An exhaustive cost-benefit analysis of population genetic testing published in Annals of Internal Medicine concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness.

Related Keywords

Pennsylvania , United States , Danville , Jonathan Schildcrout , Gregory Guzauskas , David Veenstra , Zilu Zhou , John Graves , Shawn Garbett , Josh Peterson , Emily Henderson , Vanderbilt University Medical Center , Us Centers For Disease , Geisinger Health , National Institutes Of Health , University Of Washington , Internal Medicine , Disease Control , Biomedical Informatics , Vanderbilt University Medical , Precision Medicine , Personalized Medicine , National Institutes , Genetic , Flood , Dancer , Cholesterol , Olorectal , Colorectal Cancer , Oronary Heart Disease , Familial Hypercholesterolemia , Genes , Heart , Heart Disease , Ereditary Breast And Ovarian Cancer Syndrome , Hypercholesterolemia , Lipoprotein , Lynch Syndrome , Medicine , Ovarian Cancer , Stroke , Yndrome ,